Combination chemotherapy of advanced lymphocytic lymphoma:Importance of histologic classification in evaluating response
نویسندگان
چکیده
منابع مشابه
Combination Chemotherapy of Advanced Chronic Lymphocytic Leukemia
1 1 10 Blood. Vol. 60. No. 5 (November). 1982 The M-2 protocol (vincristine. cyclophosphamide. BCNU. melphalan. and prednisone) was administered monthly to 63 evaluable patients with advanced chronic lymphocytic leukemia. Complete remission (absence of all clinical and bone marrow evidence of leukemia) and partial response (>50% decrease in organ enlargement and reduction of WBC count to below ...
متن کاملCombination Chemotherapy of Advanced Chronic Lymphocytic Leukemia : The M -
1 1 10 Blood. Vol. 60. No. 5 (November). 1982 The M-2 protocol (vincristine. cyclophosphamide. BCNU. melphalan. and prednisone) was administered monthly to 63 evaluable patients with advanced chronic lymphocytic leukemia. Complete remission (absence of all clinical and bone marrow evidence of leukemia) and partial response (>50% decrease in organ enlargement and reduction of WBC count to below ...
متن کاملCombination Chemotherapy of Advanced Chronic Lymphocytic Leukemia : The M - 2
1 1 10 Blood. Vol. 60. No. 5 (November). 1982 The M-2 protocol (vincristine. cyclophosphamide. BCNU. melphalan. and prednisone) was administered monthly to 63 evaluable patients with advanced chronic lymphocytic leukemia. Complete remission (absence of all clinical and bone marrow evidence of leukemia) and partial response (>50% decrease in organ enlargement and reduction of WBC count to below ...
متن کاملCombination Chemotherapy of Advanced
Seventy-three patients with advanced non-Hodgkin lymphoma were treated with bleomycin, Adriamycin, cyclophosphamide, vincristine (Oncovin) and prednisone (BACOP), administered intensively during a 7-wk induction course followed by intermittent cycles every 3 wk for a total of 28 wk. The objective response in 44 evaluable nonleukemic patients with diffuse histology was 86%, with 66% achieving a ...
متن کاملCombination Chemotherapy of Advanced Chronic
1 1 10 Blood. Vol. 60. No. 5 (November). 1982 The M-2 protocol (vincristine. cyclophosphamide. BCNU. melphalan. and prednisone) was administered monthly to 63 evaluable patients with advanced chronic lymphocytic leukemia. Complete remission (absence of all clinical and bone marrow evidence of leukemia) and partial response (>50% decrease in organ enlargement and reduction of WBC count to below ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cancer
سال: 1974
ISSN: 0008-543X,1097-0142
DOI: 10.1002/1097-0142(197410)34:4<1023::aid-cncr2820340410>3.0.co;2-7